Cargando…

The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer

BACKGROUND: Several surgeon characteristics are associated with the use of sentinel lymph node biopsy (SLNB) for breast cancer. No studies have systematically examined the relative contribution of both surgeon and hospital factors on receipt of SLNB. OBJECTIVE: To evaluate the relationship between s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Tina W.F., Li, Jianing, Sparapani, Rodney A., Laud, Purushuttom W., Nattinger, Ann B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979807/
https://www.ncbi.nlm.nih.gov/pubmed/27495053
http://dx.doi.org/10.1097/MD.0000000000004392
_version_ 1782447379613483008
author Yen, Tina W.F.
Li, Jianing
Sparapani, Rodney A.
Laud, Purushuttom W.
Nattinger, Ann B.
author_facet Yen, Tina W.F.
Li, Jianing
Sparapani, Rodney A.
Laud, Purushuttom W.
Nattinger, Ann B.
author_sort Yen, Tina W.F.
collection PubMed
description BACKGROUND: Several surgeon characteristics are associated with the use of sentinel lymph node biopsy (SLNB) for breast cancer. No studies have systematically examined the relative contribution of both surgeon and hospital factors on receipt of SLNB. OBJECTIVE: To evaluate the relationship between surgeon and hospital characteristics, including a novel claims-based classification of hospital commitment to cancer care (HC), and receipt of SLNB for breast cancer, a marker of quality care. DATA SOURCES/STUDY DESIGN: Observational prospective survey study was performed in a population-based cohort of Medicare beneficiaries who underwent incident invasive breast cancer surgery, linked to Medicare claims, state tumor registries, American Hospital Association Annual Survey Database, and American Medical Association Physician Masterfile. Multiple logistic regression models determined surgeon and hospital characteristics that were predictors of SLNB. RESULTS: Of the 1703 women treated at 471 different hospitals by 947 different surgeons, 65% underwent an initial SLNB. Eleven percent of hospitals were high-volume and 58% had a high commitment to cancer care. In separate adjusted models, both high HC (odds ratio [OR] 1.53, 95% confidence interval [CI] 1.12–2.10) and high hospital volume (HV, OR 1.90, 95% CI 1.28–2.79) were associated with SLNB. Adding surgeon factors to a model including both HV and HC minimally modified the effect of high HC (OR 1.34, 95% CI 0.95–1.88) but significantly weakened the effect of high HV (OR 1.25, 95% CI 0.82–1.90). Surgeon characteristics (higher volume and percentage of breast cancer cases) remained strong independent predictors of SLNB, even when controlling for various hospital characteristics. CONCLUSIONS: Hospital factors are associated with receipt of SLNB but surgeon factors have a stronger association. Since regionalization of breast cancer care in the U.S. is unlikely to occur, efforts to improve the surgical care and outcomes of breast cancer patients must focus on optimizing patient access to SLNB by ensuring hospitals have the necessary resources and training to perform SLNB, staffing hospitals with surgeons who specialize/focus in breast cancer and referring patients who do not have access to SLNB to an experienced center.
format Online
Article
Text
id pubmed-4979807
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49798072016-08-18 The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer Yen, Tina W.F. Li, Jianing Sparapani, Rodney A. Laud, Purushuttom W. Nattinger, Ann B. Medicine (Baltimore) 5750 BACKGROUND: Several surgeon characteristics are associated with the use of sentinel lymph node biopsy (SLNB) for breast cancer. No studies have systematically examined the relative contribution of both surgeon and hospital factors on receipt of SLNB. OBJECTIVE: To evaluate the relationship between surgeon and hospital characteristics, including a novel claims-based classification of hospital commitment to cancer care (HC), and receipt of SLNB for breast cancer, a marker of quality care. DATA SOURCES/STUDY DESIGN: Observational prospective survey study was performed in a population-based cohort of Medicare beneficiaries who underwent incident invasive breast cancer surgery, linked to Medicare claims, state tumor registries, American Hospital Association Annual Survey Database, and American Medical Association Physician Masterfile. Multiple logistic regression models determined surgeon and hospital characteristics that were predictors of SLNB. RESULTS: Of the 1703 women treated at 471 different hospitals by 947 different surgeons, 65% underwent an initial SLNB. Eleven percent of hospitals were high-volume and 58% had a high commitment to cancer care. In separate adjusted models, both high HC (odds ratio [OR] 1.53, 95% confidence interval [CI] 1.12–2.10) and high hospital volume (HV, OR 1.90, 95% CI 1.28–2.79) were associated with SLNB. Adding surgeon factors to a model including both HV and HC minimally modified the effect of high HC (OR 1.34, 95% CI 0.95–1.88) but significantly weakened the effect of high HV (OR 1.25, 95% CI 0.82–1.90). Surgeon characteristics (higher volume and percentage of breast cancer cases) remained strong independent predictors of SLNB, even when controlling for various hospital characteristics. CONCLUSIONS: Hospital factors are associated with receipt of SLNB but surgeon factors have a stronger association. Since regionalization of breast cancer care in the U.S. is unlikely to occur, efforts to improve the surgical care and outcomes of breast cancer patients must focus on optimizing patient access to SLNB by ensuring hospitals have the necessary resources and training to perform SLNB, staffing hospitals with surgeons who specialize/focus in breast cancer and referring patients who do not have access to SLNB to an experienced center. Wolters Kluwer Health 2016-08-07 /pmc/articles/PMC4979807/ /pubmed/27495053 http://dx.doi.org/10.1097/MD.0000000000004392 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5750
Yen, Tina W.F.
Li, Jianing
Sparapani, Rodney A.
Laud, Purushuttom W.
Nattinger, Ann B.
The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
title The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
title_full The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
title_fullStr The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
title_full_unstemmed The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
title_short The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
title_sort interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
topic 5750
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979807/
https://www.ncbi.nlm.nih.gov/pubmed/27495053
http://dx.doi.org/10.1097/MD.0000000000004392
work_keys_str_mv AT yentinawf theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT lijianing theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT sparapanirodneya theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT laudpurushuttomw theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT nattingerannb theinterplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT yentinawf interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT lijianing interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT sparapanirodneya interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT laudpurushuttomw interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer
AT nattingerannb interplaybetweenhospitalandsurgeonfactorsandtheuseofsentinellymphnodebiopsyforbreastcancer